Ftse Mib
37.977,59
0,18%
DAX
22.513,42
-0,43%
S&P 500
6.114,63
-0,01%
NASDAQ
20.026,77
0,41%
Bitcoin
97.168,21
-0,44%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Supernus Pharmaceuticals Inc (SUPN) Supernus Pharmaceuticals Inc (SUPN) Notizie

Supernus Pharmaceuticals Inc

SUPN
39,11
-0,42 (-1,06%)
15 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/2/202523:20EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
11/2/202523:13EDGAR2Form 8-K - Current report
11/2/202522:30GLOBESupernus Pharmaceuticals to Host Conference Call and Webcast..
06/2/202522:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202522:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202522:23EDGAR2Form 8-K - Current report
04/2/202515:00GLOBESupernus Announces FDA Approval of ONAPGO™ (apomorphine..
29/1/202523:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202523:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202522:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/1/202522:26EDGAR2Form 144 - Report of proposed sale of securities
27/1/202522:20EDGAR2Form 8-K - Current report
27/1/202514:00GLOBESupernus Announces Label Update for Non-Stimulant ADHD..
30/12/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202414:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202414:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202422:10EDGAR2Form 8-K - Current report
16/12/202422:30GLOBEKnight Therapeutics Announces Filing of New Drug Submission..
04/12/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202422:31EDGAR2Form 144 - Report of proposed sale of securities
26/11/202423:00GLOBESupernus to Participate in the 36th Annual Piper Sandler..
14/11/202423:14EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/11/202422:30GLOBESupernus Pharmaceuticals to Participate in the 2024..
12/11/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202423:00EDGAR2Form 144 - Report of proposed sale of securities
08/11/202422:33EDGAR2Form 144 - Report of proposed sale of securities
08/11/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202422:59EDGAR2Form 144 - Report of proposed sale of securities
07/11/202422:55EDGAR2Form 144 - Report of proposed sale of securities
04/11/202422:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/11/202422:13EDGAR2Form 8-K - Current report
04/11/202422:05GLOBESupernus Announces Third Quarter 2024 Financial Results
01/11/202421:35EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
31/10/202421:10GLOBESupernus Presents Promising Data from Open-Label Phase 2a..
30/10/202421:38EDGAR2Form 8-K - Current report
21/10/202422:48EDGAR2Form 8-K - Current report
21/10/202422:25GLOBESupernus Pharmaceuticals to Host Conference Call and Webcast..
18/10/202412:09IHMARKETNEWSiPhone 16 Sales in China Up 20%; Sobr Safe Jumps 108%..
17/10/202422:16EDGAR2Form 8-K - Current report
17/10/202422:05GLOBESupernus Announces Promising Data from Open-Label Phase 2a..
10/10/202423:12GLOBESupernus Pharmaceuticals to Host Webcast to Review..
10/10/202423:03EDGAR2Form 8-K - Current report
24/9/202413:30GLOBEBusy Philipps Encourages Women to Take Charge of Their ADHD..
19/9/202422:30GLOBESupernus Pharmaceuticals to Participate in the TD Cowen 4th..
03/9/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202422:15GLOBESupernus Pharmaceuticals to Participate in the 2024 Wells..
27/8/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 39,59 Min: 38,98 Max: 39,59
Chiusura: 39,53

La tua Cronologia

NASDAQ
SUPN
Supernus Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci